Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05458258 · ClinicalTrials.gov registry record
Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 239
- Enrollment target
NCT05458258 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 239 participants.
The verdict
NCT05458258 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 239 participants
- Enrollment target
Study Summary
This study will explore how malnutrition (poor nutrition/diet) and sarcopenia (a condition that causes a loss of muscle and bone mass) affects study participants over the age of 60 with acute myeloid leukemia (AML) who will receive induction chemotherapy (chemotherapy given as the first treatment to help cancer go into remission) and/or cancer drugs as part of standard care for AML. By studying how these nutritional and skeletal factors, doctors leading this study hope to learn how malnutrition and sarcopenia may be able to predict certain outcomes --such as how long study participants with poor nutrition and muscle loss can live after chemotherapy- for older (age 60+) individuals with AML.
Interventions
- DEVICE Bioelectrical Impedence Analysis Device
- OTHER 6 Minute Walk Test
- DIAGNOSTIC_TEST Computed Tomography Scans to Measure Skeletal Muscular Index
- DIAGNOSTIC_TEST Blood Test/Blood Draw
- OTHER Hand Grip Strength Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2025-04-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05458258
The ClinicalTrials.gov registry entry for NCT05458258 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Bioelectrical Impedence Analysis Device is the first listed.
NCT05458258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05458258 about?
NCT05458258 is a clinical study titled "Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia". This study will explore how malnutrition (poor nutrition/diet) and sarcopenia (a condition that causes a loss of muscle and bone mass) affects study participants over the age of 60 with acute myeloid leukemia (AML) who will receive induction chemotherapy (chemotherapy given as the first treatment to...
What is the current status of trial NCT05458258?
This trial is currently completed. The enrollment target is 239 participants. The study started on 2023-03-01. Estimated completion is 2025-04-18.
What interventions are being tested in trial NCT05458258?
The interventions under investigation include: Bioelectrical Impedence Analysis Device (DEVICE), 6 Minute Walk Test (OTHER), Computed Tomography Scans to Measure Skeletal Muscular Index (DIAGNOSTIC_TEST), Blood Test/Blood Draw (DIAGNOSTIC_TEST), Hand Grip Strength Test (OTHER).
Who is sponsoring clinical trial NCT05458258?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.